Cargando…

Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning

There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Alysia, Mendez, Dara D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804229/
https://www.ncbi.nlm.nih.gov/pubmed/35112047
http://dx.doi.org/10.1089/heq.2021.0122
_version_ 1784643029801369600
author Davis, Alysia
Mendez, Dara D.
author_facet Davis, Alysia
Mendez, Dara D.
author_sort Davis, Alysia
collection PubMed
description There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities.
format Online
Article
Text
id pubmed-8804229
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Mary Ann Liebert, Inc., publishers
record_format MEDLINE/PubMed
spelling pubmed-88042292022-02-01 Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning Davis, Alysia Mendez, Dara D. Health Equity Perspective There are a disproportionate number of cases, hospitalizations, and deaths among Black and Latinx communities, a result of a history of structural racism and exploitation. An equity framework and approach are critical but have been lacking in the COVID-19 response, including vaccine dissemination. We provide an overview and application of remove, repair, remediate, restructure, and provide (R4P), an equity framework, in examining COVID-19 vaccine trial development and related interventions. R4P is an equity framework and tool that applies critical race theory, intersectional, and dimensionality in planning, assessment, and research for creating action to eliminate inequities. Mary Ann Liebert, Inc., publishers 2022-01-25 /pmc/articles/PMC8804229/ /pubmed/35112047 http://dx.doi.org/10.1089/heq.2021.0122 Text en © Alysia Davis and Dara D. Mendez 2022; Published by Mary Ann Liebert, Inc. https://creativecommons.org/licenses/by/4.0/This Open Access article is distributed under the terms of the Creative Commons License [CC-BY] (http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Davis, Alysia
Mendez, Dara D.
Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title_full Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title_fullStr Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title_full_unstemmed Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title_short Applications of an Equity Framework in COVID-19 Vaccine Trial and Distribution Planning
title_sort applications of an equity framework in covid-19 vaccine trial and distribution planning
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804229/
https://www.ncbi.nlm.nih.gov/pubmed/35112047
http://dx.doi.org/10.1089/heq.2021.0122
work_keys_str_mv AT davisalysia applicationsofanequityframeworkincovid19vaccinetrialanddistributionplanning
AT mendezdarad applicationsofanequityframeworkincovid19vaccinetrialanddistributionplanning